Finland
· Delayed Price · Currency is EUR Biohit Oyj Statistics
Total Valuation
Biohit Oyj has a market cap or net worth of EUR 32.93 million. The enterprise value is 28.63 million.
| Market Cap | 32.93M |
| Enterprise Value | 28.63M |
Important Dates
The last earnings date was Thursday, August 29, 2024.
| Earnings Date | Aug 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biohit Oyj has 15.17 million shares outstanding. The number of shares has increased by 0.51% in one year.
| Shares Outstanding | 15.17M |
| Shares Change (YoY) | +0.51% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 19.37% |
| Owned by Institutions (%) | n/a |
| Float | 7.02M |
Valuation Ratios
The trailing PE ratio is 19.89 and the forward PE ratio is 16.69.
| PE Ratio | 19.89 |
| Forward PE | 16.69 |
| PS Ratio | 2.35 |
| PB Ratio | 3.05 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.70, with an EV/FCF ratio of -52.43.
| EV / Earnings | 17.34 |
| EV / Sales | 2.05 |
| EV / EBITDA | 13.70 |
| EV / EBIT | 16.60 |
| EV / FCF | -52.43 |
Financial Position
The company has a current ratio of 4.30, with a Debt / Equity ratio of 6.48.
| Current Ratio | 4.30 |
| Quick Ratio | 3.97 |
| Debt / Equity | 6.48 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | -1.28 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 16.68% and return on invested capital (ROIC) is 10.12%.
| Return on Equity (ROE) | 16.68% |
| Return on Assets (ROA) | 8.08% |
| Return on Capital (ROIC) | 10.12% |
| Revenue Per Employee | 297,362 |
| Profits Per Employee | 35,128 |
| Employee Count | 47 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 6.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.50% in the last 52 weeks. The beta is 0.85, so Biohit Oyj's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +8.50% |
| 50-Day Moving Average | 2.16 |
| 200-Day Moving Average | 2.01 |
| Relative Strength Index (RSI) | 49.44 |
| Average Volume (20 Days) | 11,839 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biohit Oyj had revenue of EUR 13.98 million and earned 1.65 million in profits. Earnings per share was 0.11.
| Revenue | 13.98M |
| Gross Profit | 8.56M |
| Operating Income | 1.73M |
| Pretax Income | 1.90M |
| Net Income | 1.65M |
| EBITDA | 1.83M |
| EBIT | 1.73M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 5.00 million in cash and 700,000 in debt, giving a net cash position of 4.30 million or 0.28 per share.
| Cash & Cash Equivalents | 5.00M |
| Total Debt | 700,000 |
| Net Cash | 4.30M |
| Net Cash Per Share | 0.28 |
| Equity (Book Value) | 10.80M |
| Book Value Per Share | 0.71 |
| Working Capital | 9.90M |
Cash Flow
In the last 12 months, operating cash flow was -198,000 and capital expenditures -348,000, giving a free cash flow of -546,000.
| Operating Cash Flow | -198,000 |
| Capital Expenditures | -348,000 |
| Free Cash Flow | -546,000 |
| FCF Per Share | -0.04 |
Margins
Gross margin is 61.28%, with operating and profit margins of 12.34% and 11.81%.
| Gross Margin | 61.28% |
| Operating Margin | 12.34% |
| Pretax Margin | 13.56% |
| Profit Margin | 11.81% |
| EBITDA Margin | 13.12% |
| EBIT Margin | 12.34% |
| FCF Margin | -3.91% |
Dividends & Yields
Biohit Oyj does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.51% |
| Shareholder Yield | -0.51% |
| Earnings Yield | 5.03% |
| FCF Yield | -1.66% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |